Estuardo Aguilar-Cordova

Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery.

A. Beaudet, H. Zhou, B. Mull, 1998, Human gene therapy.

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

P. Scardino, T. Wheeler, T. Timme, 1999, Human gene therapy.

TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines.

A. Rice, D. Lewis, C. H. Herrmann, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys.

S. Rajagopalan, M. Lieberman, P. Overbeek, 1993, The American journal of pathology.

Improved Effects of Viral Gene Delivery of Human Upa plus Biliodigestive Anastomosis Induce Recovery from Experimental Biliary Cirrhosis

J. Armendáriz-Borunda, J. Berumen, A. Miranda-Díaz, 2022 .

Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.

P. Scardino, B. Miles, T. Thompson, 2000, The Journal of urology.

Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up.

I. Ramzy, A. Hasenburg, D. Kieback, 2001, Gynecologic oncology.

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.

T. Wheeler, B. Miles, C. Ren, 2001, Human gene therapy.

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.

E. B. Butler, T. Wheeler, B. Miles, 2001, International journal of radiation oncology, biology, physics.

A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects.

L. Donehower, J. Belmont, D. Lewis, 1994, AIDS research and human retroviruses.